Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
12 Fevereiro 2025 - 3:05PM
Edgar (US Regulatory)
Exhibit 1
JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the
foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement
on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements.
The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy
of the information concerning such person contained therein, but shall not be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that such person knows or has reason to believe that such information is inaccurate.
Dated: February 12, 2025
|
Havlickova 648 a.s. |
|
|
|
|
By: |
/s/ Miroslav Dornak |
|
|
Miroslav Dornak |
|
|
Authorized Signatory |
|
|
|
|
Dubnica Property s.r.o. |
|
|
|
|
By: |
/s/ Miroslav Dornak |
|
|
Miroslav Dornak |
|
|
Authorized Signatory |
|
|
|
|
By: |
/s/ Miroslav Dornak |
|
|
Miroslav Dornak |
Cadrenal Therapeutics (NASDAQ:CVKD)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Cadrenal Therapeutics (NASDAQ:CVKD)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025